JCO Article Insights: LEAP-010 Study in Recurrent/Metastatic Head and Neck Cancer
Host Jake New summarizes and offers insights into the JCO article by Licitra et al., "Pembrolizumab With or Without Lenvatinib as First-Line...
Radio and PodcastLive Radio & PodcastsScience & Medicine
Journal of Clinical Oncology (JCO) Podcast
The Journal of Clinical Oncology (JCO) serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. Usually presented in c...
Journal of Clinical Oncology (JCO) Podcast Podcast Guide
Listen to Journal of Clinical Oncology (JCO) Podcast, a Science & Medicine podcast by Journals Online Team. Stream 455 episodes in English, follow new audio stories, and play episodes online on Radio and Podcast.
Show Topic
Browse this show under Science & Medicine podcasts.
Episodes
20 episodes are loaded now from a catalog of 455. More episodes can be opened from this page.
Discover More
Explore Science & Medicine podcasts, United States podcasts and English podcasts.
Episodes
20 of 455 episodes
Infections in Two Diet Strategies in HSCT and Leukemia Patients
Guest Dr. John Wingard and host Dr. Davide Soldato discuss JCO article, " Randomized Non-inferiority Trial of a Liberalized Diet Versus the...
JCO Article Insights: ctDNA in DLBCL - Ready for Prime Time?
In this episode of JCO Article Insights, host Dr. Ash Gurumurthi summarizes JCO articles, " Phased Variant–Supported Circulating Tumor DNA a...
The CISTO Study: Radical Cystectomy or Bladder-Sparing Therapy for Recurrent NMIBC
Guest Dr. John Gore and host Dr. Davide Soldato discuss JCO article, " 12-Month Results from the CISTO Study Comparing Radical Cystectomy Ve...
JCO Article Insights: Atezolizumab, Bevacizumab, and Non-Platinum Chemotherapy for PROC
In this episode of JCO Article Insights, host Dr. Melis Canturk summarizes the article, " Atezolizumab With Bevacizumab and Nonplatinum Chem...
JCO Article Insights: Ribociclib Plus Letrozole in Recurrent LGSOC: GOG 3026
In this episode of JCO Article Insights, host Dr. Melis Canturk summarizes the article, " Phase 2 Trial of Ribociclib plus Letrozole in Wome...
NCI Working Group on Biochemically Recurrent Prostate Cancer
Host Dr. Davide Soldato and guests Dr. David Einstein and Dr. Ravi Madan discuss JCO article, " National Cancer Institute's Working Group on...
Association Between EOL SACT and Healthcare Utilization
Host Dr. Davide Soldato and guests Dr. Kerin Adelson and Dr. Maureen Canavan discuss JCO article " Association Between Systemic Anticancer T...
Milan Consensus Endpoints for Bladder Preservation in MIBC
Guests Dr. Andrea Necchi, Dr. Ashish Kamat and host Dr. Davide Soldato discuss JCO article " End Points for the Next-Generation Bladder-Spar...
JCO at 2025 ASH: Pirtobrutinib in Untreated CLL
JCO Editor-in-Chief Dr. Jonathan Friedberg is joined by colleagues Dr. Jennifer Woyach, Dr. Wojciech Jurczak, and Dr. Matthew Davids to disc...
JCO at ASH 2025: A New Validated Staging System for AL Amyloidosis: AL-ISS
JCO Editorial Fellow Peter Li and author Dr. Jahanzaib Khwaja discuss the ASH 2025 Simultaneous Publication article, " A New Validated Stagi...
JCO Article Insights: Simultaneous Durvalumab and CRT in Unresectable Stage III NSCLC
In this episode of JCO Article Insights, host Dr. Ece Cali Daylan interviews author Dr. Jeffrey Bradley about the article, " Simultaneous Du...
Health Outcomes in Older Childhood Cancer Survivors
Guest Dr. Rusha Bhandari and host Dr. Davide Soldato discuss JCO article "Health Outcomes Beyond Age 50 Years in Survivors of Childhood Canc...
Long-Term Remission After Cilta-cel in Patients With RRMM
Guest Dr. Sundar Jagannath and host Dr. Davide Soldato discuss JCO article " Long-Term (≥5-Year) Remission and Survival After Treatment With...
JCO Article Insights: Xevinapant Plus Chemoradiotherapy in Unresected LA SCCHN
In this episode of JCO Article Insights, host Dr. Lauren Shih summarizes the article, " Xevinapant or Placebo Plus Platinum-Based Chemoradio...
Income Among Adolescents and Young Adults Surviving Cancer
Host Dr. Shannon Westin and guest Dr. Giancarlo Di Guiseppe discuss the JCO article " Long-Term Dynamic Financial Impacts Among Adolescents...
JCO Article Insights: Phase I DLL3/CD3 T-Cell Engager in DLL3-Positive SCLC or NECs
In this JCO Article Insights episode, Dr. Ece Cal interviews Dr. Martin Wermke, author of the JCO article, " Phase I Dose-Escalation Results...
TTFields in Locally Advanced Pancreatic Adenocarcinoma
Host Dr. Shannon Westin and guest Dr. Hani Babiker discuss the JCO article " Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for L...
JCO at WCLC: Multinational Pivotal Study of Sunvozertinib in Exon20ins NSCLC
JCO fellow Dr. Ece Cali speaks with JCO Associate Editor Dr. Thomas E. Stinchcombe to discuss the JCO article "Phase 2 Dose-Randomized Study...
Racial and Ethnic Disparities Among Medicare Beneficiaries
Host Davide Soldato and guest Dr. John K. Lin discuss the JCO article " Racial and Ethnic Disparities Along the Treatment Cascade Among Medi...